-
Loading metrics
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study
-
Vianney Tricou ,
Roles Conceptualization, Formal analysis, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing
* E-mail: vianney.tricou@takeda.com
Affiliation Takeda Pharmaceuticals International AG, Zurich, Switzerland
⨯ - Brandon Essink,
- John E. Ervin,
- Mark Turner,
- Ian Escudero,
- Martina Rauscher,
- Manja Brose,
- Inge Lefevre,
- Astrid Borkowski,
- Derek Wallace
https://orcid.org/0000-0002-5465-8647
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study
- Vianney Tricou,
- Brandon Essink,
- John E. Ervin,
- Mark Turner,
- Ian Escudero,
- Martina Rauscher,
- Manja Brose,
- Inge Lefevre,
- Astrid Borkowski,
- Derek Wallace
x
- Published: March 8, 2023
- https://doi.org/10.1371/journal.pntd.0011124